4D Molecular Therapeutics, Inc. (FDMT) › Shareholders' Equity4D Molecular Therapeutics, Inc. (FDMT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$27.59M2019: -$72.97M2020: $256.39M2021: $319.11M2022: $231.34M2023: $307.83M2024: $510.61M2025: $505.66M$505.66M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$505.66M-1.0%2024$510.61M+65.9%2023$307.83M+33.1%2022$231.34M-27.5%2021$319.11M+24.5%2020$256.39M+451.4%2019-$72.97M-164.5%2018-$27.59M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share